Dr Lal Pathlab Group CFO on Business Outlook

The transcript discusses the company's focus on growing its non-COVID business, which has seen a 28% growth in Q3. The company is expanding both organically and inorganically, with a focus on increasing its presence in Tier 2 and Tier 3 cities. Despite acquisitions impacting earnings, the company aims to grow through volume while maintaining margins. Supply chain management has been effective, with no significant disruptions in the supply of test kits.

What was the growth percentage of the company's non-COVID businesses in Q3?

• 15%

• 28%

• 35%

• 10%

Which regions are the company's core geographies for organic growth?

• North and East

• South and West

• North and South

• Central and East

What recent acquisition did the company make in the West region?

• Suburban Diagnostic

• Urban Health

• Metro Labs

• City Diagnostics

What is the company's approach to maintaining financial health while expanding?

• Reducing operational costs

• Focusing on volume growth

• Increasing prices

• Expanding only in core regions

How has the company managed supply chain disruptions?

• By increasing local production

• By stockpiling resources

• By maintaining strong supplier relationships

• By reducing dependency on imports